X0407 4 2023-05-15 0 0001831097 agilon health, inc. AGL 0001855843 Shaker Benjamin C/O AGILON HEALTH, INC. 6210 E HWY 290, SUITE 450 AUSTIN TX 78723 0 1 0 0 Chief Markets Officer 1 Common Stock 2023-05-15 4 M 0 25000 3.00 A 104543 D Common Stock 2023-05-15 4 S 0 25000 23.7893 D 79543 D Common Stock 2023-05-16 4 M 0 25000 3.00 A 104543 D Common Stock 2023-05-16 4 S 0 25000 23.1414 D 79543 D Options (Right to buy) 3.00 2023-05-15 4 M 0 25000 0.00 D 2027-04-27 Common Stock 25000 26851 D Options (Right to buy) 3.00 2023-05-16 4 M 0 25000 0.00 D 2027-04-27 Common Stock 25000 1851 D Includes restricted stock units. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan effective September 15, 2022. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.43 to $24.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.74 to $23.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. These options were granted on April 27, 2017, and became fully vested as of September 14, 2021. /s/ Steve Meetre, as Attorney-in-Fact 2023-05-17